Brevetti EPO No.3313528 2021.08.04
Brevetti EPO
(10) Registration Number and Date
2021000567 2021.10.04
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2021/000567 2016.06.28
(40) Publication Number and Date
SM /T/2021/000567 2021.10.04
(30) Priority Details
US 201562262574 P
2015.12.03
US 201562239965 P
2015.10.11
US 201562185968 P
2015.06.29
(71/73) Applicant
(72) Inventor
(IT) MULLIGAN, Christopher Lee : c/o Bristol-Myers Squibb CompanyRoute 206 and Province Line Road, Princeton, New Jersey 08543, US
(IT) BARTLETT, Justin Blake : 9 Coddington CT., Basking Ridge, New Jersey 07920, US
(IT) ROBBINS, Michael Darron : c/o Bristol-Myers Squibb CompanyRoute 206 and Province Line Road, Princeton, New Jersey 08543, US
(74) Representative Name
(IT) SANTORO, Tiziana : Via 28 Luglio, 187, 47893 Borgo Maggiore RSM, SM
(54) Title
(IT) REGIMI DI DOSAGGIO IMMUNOTERAPEUTICO COMPRENDENTE POMALIDOMIDE E UN ANTICORPO ANTI-CS1 PER IL TRATTAMENTO DI UN CANCRO
(EN) IMMUNOTHERAPEUTIC DOSING REGIMENS COMPRISING POMALIDOMIDE AND AN ANTI-CS1 ANTIBODY FOR TREATING CANCER
(57) Abstract
(58) Citations